Click here for Live Streaming.
More than half of newly approved cancer drugs are administered orally. Oral oncolytics make therapy more manageable and convenient for patients, but they also pose potential challenges in regards to adherence. Take an in-depth look at the issues surrounding adherence, including evidence-based interventions and research gaps. You’ll come away with tools to improve outcomes for your patients.
Objectives
